Using a novel surgical approach, it’s possible to rebuild the trachea and preserve a patient’s voice after removing an invasive throat tumor, according to a new report from Henry Ford Hospital in…
Month: February 2011
Advaxis Science & Operations Officer Moderates Live Vaccine Panel At Cancer Drug Research Conference
Dr. John Rothman, EVP of Science & Operations of Advaxis, Inc., (OTCBB: ADXS) the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, moderated a panel discussion titled, “Live Cancer Vaccines.” Topics addressed by…
Tracing The Evolutionary Path Of Multidrug-Resistant Strep Bacteria
Despite penicillin and the dozens of antibiotics that followed it, streptococcus bacteria have remained a major threat to health throughout the world. The reason: the superb evolutionary skills of this pathogen to…